Skip to main content
Close Search
BIVDA NewsletterBIVDA NewsletterBIVDA Newsletter
search
Menu
  • Home
  • Consultations
  • Events Diary
  • Highlights Archive
  • Membership News Archive
  • Regulatory Newsletter
  • Tenders
  • Training
    • In-Person Events
    • Webinars
  • Funding Opportunities
  • Working Party News
    • Working Party Archive
      • AMR Taskforce Archive
      • Covid 19 Taskforce Archive
      • Digital Working Party Archive
      • Environmental Working Party Archive
      • European Affairs Archive
      • Export Working Party Archive
      • External Affairs Working Party
      • Genomics Working Party Archive
      • Market Dynamics Archive
      • Near Patient Testing Working Party Archive
      • Regulatory Affairs Working Party Archive
      • Infectious Diseases Working Party Archive
      • Procurement Working Party Archive
  • search
Category

MedTech Europe Updates Environmental Newsletter

ECHA recent substance developments European Chemicals Agency Updates Environmental NewsletterEuropean Chemicals Agency Updates Environmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

ECHA recent substance developments

Based on the weekly ECHA updates, the recent substance developments include: REACH: Bis(2-methoxyethyl) ether (Diglyme): ECHA published a screening report to assess whether the use of this substance in articles should be restricted. creosote and creosote related substances: ECHA published the compiled opinion of RAC and SEAC on the restriction proposal for this substance. Stilbenesulfonic acid ditriazine dyes: ECHA published…
admin
adminMarch 6, 2024
MedTech Europe Sustainability and Environmental update MedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

MedTech Europe Sustainability and Environmental update

Please note this is an extract of the original bulletin. Corporate Sustainability Due Diligence Directive update The Directive on corporate sustainability due diligence was nearing the adoption of the CS3D text by the end of 2023 through the agreement reached between the European Parliament and the Council. The rules were aimed at fostering sustainable and responsible corporate behaviour and to…
admin
adminFebruary 28, 2024
ECHA calls for evidence for proposal to ban UV-328 European Chemicals Agency Updates Environmental NewsletterEuropean Chemicals Agency Updates Environmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

ECHA calls for evidence for proposal to ban UV-328

UV stabilisers commonly found in plastics are: UV-328 (EC: 247-384-8; CAS: 25973-55-1), UV-327 (EC: 223-383-8; CAS: 3864-99-1), UV-350 (EC: 253-037-1; CAS: 36437-37-3), UV-320 (EC: 223-346-6; CAS: 3846-71-7) ) After its inclusion into Annex A to the Stockholm Convention, ECHA opened a call for comments and evidence for UV-328. This consultation closed on 18 August 2023. ECHA published its screening report…
admin
adminJanuary 31, 2024
Potential inclusion of Lead in REACH Annex XIV European Chemicals Agency Updates Environmental NewsletterEuropean Chemicals Agency Updates Environmental Newsletter ArchiveEuropean Commission Updates Environmental NewsletterEuropean Commission Updates Environmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

Potential inclusion of Lead in REACH Annex XIV

The EU have proposed to add Lead to the EU REACH Annex XIV Substances subject to authorization. Background: In 2022, ECHA launched a public consultation on whether Lead should be included in the REACH Authorisation list. MedTech Europe submitted its feedback advising against such a listing, mainly because most of the uses are already covered under RoHS (exemptions) and the…
admin
adminJanuary 24, 2024
Update on EU RoHS Pack 27 questionnaire consultations European Chemicals Agency Updates Environmental NewsletterEuropean Chemicals Agency Updates Environmental Newsletter ArchiveEuropean Commission Updates Environmental NewsletterEuropean Commission Updates Environmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

Update on EU RoHS Pack 27 questionnaire consultations

MedTech Europe recently sent a letter to the Commission and the Consultant BIOIS on the RoHS Pack 27 Annex III lead exemption consultations (launched by the Consultant in Q4 2023). DG Environment responded to MTE’s arguments and noted that “Electrical and electronic equipment (EEE) under category 8 ‘medical devices’ is often not comparable with EEE from other categories. As you…
admin
adminJanuary 9, 2024
ECHA recommendation report on PVC and its additives European Chemicals Agency Updates Environmental NewsletterEuropean Chemicals Agency Updates Environmental Newsletter ArchiveEuropean Commission Updates Environmental NewsletterEuropean Commission Updates Environmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

ECHA recommendation report on PVC and its additives

MedTech Europe are collecting feedback on ECHA’s report advising the Commission that regulatory action is needed at EU level on PVC and its additives and responding to this EC proposal. The Annexes to the report are available at here. BIVDA members are invited to review the report and share with us your findings. The MedTech Europe Secretariat have reviewed the…
admin
adminDecember 15, 2023
ECHA calls for evidence for UV-328 – deadline 18 August European Chemicals Agency Updates Environmental NewsletterEuropean Chemicals Agency Updates Environmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

ECHA calls for evidence for UV-328 – deadline 18 August

After its inclusion into Annex A to the Stockholm Convention, ECHA has opened a call for comments and evidence for UV-328.  This call will remain open until 18 August. This call aims to ‘gather comments on the draft screening report prepared according to REACH Article 69(2)’, and to gather information on the following points: Uses of the four phenolic benzotriazoles…
admin
adminJune 2, 2023
Inclusion of Dechlorane Plus in Annex A to the Stockholm Convention MedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

Inclusion of Dechlorane Plus in Annex A to the Stockholm Convention

Following the proposal in September 2022, Dechlorane Plus has been included in Annex A (Elimination) to the Stockholm Convention on 15 May. This Annex requests Parties to ‘take measures to eliminate the production and use of the chemicals listed’. In the UK, this falls under the POPs legislation. This information is kindly provided by MedTech Europe.
admin
adminMay 19, 2023
Outcome of consultation on RoHS exemption for the use of lead in PVC European Commission Updates Environmental NewsletterEuropean Commission Updates Environmental Newsletter ArchiveMedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

Outcome of consultation on RoHS exemption for the use of lead in PVC

Following a consultation on a new RoHS exemption for the use of lead in PVC used as a base material in sensors for IVDs (category 8), the European Commission has adopted its decision, which is for the exemption to expire on 31 December 2023. BIVDA members did not provide feedback on this topic. This information is kindly provided by MedTech Europe.
admin
adminMay 19, 2023
Request: Feedback on Glutaral MedTech Europe Updates Environmental NewsletterMedTech Europe Updates Environmental Newsletter Archive

Request: Feedback on Glutaral

MedTech Europe are requesting feedback on Glutaral and associated information. If your organisation uses this substance, we would appreciate your feedback on: The intermediate use definition stated in REACH in relation to Glutaral, and whether is it an appropriate definition What impact would result from the use of Glutaral as a cross-linker or auxiliary in the manufacturing process Members are…
admin
adminMay 19, 2023
  • Previous
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next

Email us
membership@bivda.org.uk

Call us
+44 (0) 333 3208 823

Website
www.bivda.org.uk

Find us
299 Oxford Street (5th floor)
London, W1C 2DZ

© Copyright 2026 BIVDA Ltd is registered in England, with Company Number 2687137 Registered Office is 299 Oxford Street (5th floor), London, W1C 2DZ. VAT Number 563105858
Web Design by WDAT

  • twitter
  • linkedin
Close Menu
  • Home
  • Consultations
  • Events Diary
  • Highlights Archive
  • Membership News Archive
  • Regulatory Newsletter
  • Tenders
  • Training
    • In-Person Events
    • Webinars
  • Funding Opportunities
  • Working Party News
    • Working Party Archive
      • AMR Taskforce Archive
      • Covid 19 Taskforce Archive
      • Digital Working Party Archive
      • Environmental Working Party Archive
      • European Affairs Archive
      • Export Working Party Archive
      • External Affairs Working Party
      • Genomics Working Party Archive
      • Market Dynamics Archive
      • Near Patient Testing Working Party Archive
      • Regulatory Affairs Working Party Archive
      • Infectious Diseases Working Party Archive
      • Procurement Working Party Archive